메뉴 건너뛰기




Volumn 292, Issue 3, 2007, Pages

Thiazolidinediones improve β-cell function in type 2 diabetic patients

Author keywords

Insulin secretion; Insulin secretion insulin resistance index; Type 2 diabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; PIOGLITAZONE; PLACEBO; ROSIGLITAZONE; SULFONYLUREA;

EID: 33947144118     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00551.2006     Document Type: Article
Times cited : (174)

References (66)
  • 1
    • 33745325861 scopus 로고    scopus 로고
    • Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: Results from the Veterans Administration Genetic Epidemiology Study
    • Abdul-Ghani MA, Jenkinson CP, Richardson DK, Tripathy D, DeFronzo RA. Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the Veterans Administration Genetic Epidemiology Study. Diabetes 55: 1430-1435, 2006.
    • (2006) Diabetes , vol.55 , pp. 1430-1435
    • Abdul-Ghani, M.A.1    Jenkinson, C.P.2    Richardson, D.K.3    Tripathy, D.4    DeFronzo, R.A.5
  • 2
    • 0141446274 scopus 로고    scopus 로고
    • Characterization of GLP-1 effects on beta-cell function after meal ingestion in humans
    • Ahren B, Holst JJ, Mari A. Characterization of GLP-1 effects on beta-cell function after meal ingestion in humans. Diabetes Care 26: 2860-2864, 2003.
    • (2003) Diabetes Care , vol.26 , pp. 2860-2864
    • Ahren, B.1    Holst, J.J.2    Mari, A.3
  • 3
    • 33947169057 scopus 로고    scopus 로고
    • Ahren B, Taborsky GJ. Beta-cell function and insulin secretion. In: Ellenberg Rifkins Diabetes Mellitus, edited by Porte D, Sherwin RS, and Baron A. New York: McGraw Hill, 2003, p. 43-65.
    • Ahren B, Taborsky GJ. Beta-cell function and insulin secretion. In: Ellenberg Rifkins Diabetes Mellitus, edited by Porte D, Sherwin RS, and Baron A. New York: McGraw Hill, 2003, p. 43-65.
  • 4
    • 77049274176 scopus 로고
    • Measurement of size and turnover rate of body glucose pool by the isotope dilution method
    • Altszuler N, De Bodo RC, Steele R, Wall JS. Measurement of size and turnover rate of body glucose pool by the isotope dilution method. Am J Physiol 187: 15-24, 1956.
    • (1956) Am J Physiol , vol.187 , pp. 15-24
    • Altszuler, N.1    De Bodo, R.C.2    Steele, R.3    Wall, J.S.4
  • 5
    • 2942515930 scopus 로고    scopus 로고
    • Plasma resistin concentration, hepatic fat content, and hepatic and peripheral insulin resistance in pioglitazone-treated type II diabetic patients
    • Bajaj M, Suraamornkul S, Hardies LJ, Pratipanawatr T, DeFronzo RA. Plasma resistin concentration, hepatic fat content, and hepatic and peripheral insulin resistance in pioglitazone-treated type II diabetic patients. Int J Obes Relat Metab Disord 28: 783-789, 2004.
    • (2004) Int J Obes Relat Metab Disord , vol.28 , pp. 783-789
    • Bajaj, M.1    Suraamornkul, S.2    Hardies, L.J.3    Pratipanawatr, T.4    DeFronzo, R.A.5
  • 6
    • 0842313004 scopus 로고    scopus 로고
    • Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients
    • Bajaj M, Suraamornkul S, Piper P, Hardies LJ, Glass L, Cersosimo E, Pratipanawatr T, Miyazaki Y, DeFronzo RA. Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients. J Clin Endocrinol Metab 89: 200-206, 2004.
    • (2004) J Clin Endocrinol Metab , vol.89 , pp. 200-206
    • Bajaj, M.1    Suraamornkul, S.2    Piper, P.3    Hardies, L.J.4    Glass, L.5    Cersosimo, E.6    Pratipanawatr, T.7    Miyazaki, Y.8    DeFronzo, R.A.9
  • 7
    • 1442352339 scopus 로고    scopus 로고
    • Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: Peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach
    • Bays H, Mandarino L, DeFronzo RA. Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach. J Clin Endocrinol Metab 89: 463-478, 2004.
    • (2004) J Clin Endocrinol Metab , vol.89 , pp. 463-478
    • Bays, H.1    Mandarino, L.2    DeFronzo, R.A.3
  • 8
    • 0036183630 scopus 로고    scopus 로고
    • The mechanisms of action of PPARs
    • Berger J, Moller DE. The mechanisms of action of PPARs. Annu Rev Med 53: 409-435, 2002.
    • (2002) Annu Rev Med , vol.53 , pp. 409-435
    • Berger, J.1    Moller, D.E.2
  • 9
    • 0036615275 scopus 로고    scopus 로고
    • The evolution of beta-cell dysfunction and insulin resistance in type 2 diabetes
    • Bergman RN, Finegood DT, Kahn SE. The evolution of beta-cell dysfunction and insulin resistance in type 2 diabetes. Eur J Clin Invest 32, Suppl 3: 35-45, 2002.
    • (2002) Eur J Clin Invest , vol.32 , Issue.SUPPL. 3 , pp. 35-45
    • Bergman, R.N.1    Finegood, D.T.2    Kahn, S.E.3
  • 10
    • 0036724346 scopus 로고    scopus 로고
    • Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women
    • Buchanan TA, Xiang AH, Peters RK, Kjos SL, Marroquin A, Goico J, Ochoa C, Tan S, Berkowitz K, Hodis HN, Azen SP. Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women. Diabetes 51: 2796-2803, 2002.
    • (2002) Diabetes , vol.51 , pp. 2796-2803
    • Buchanan, T.A.1    Xiang, A.H.2    Peters, R.K.3    Kjos, S.L.4    Marroquin, A.5    Goico, J.6    Ochoa, C.7    Tan, S.8    Berkowitz, K.9    Hodis, H.N.10    Azen, S.P.11
  • 12
    • 0030762562 scopus 로고    scopus 로고
    • Treatment with the oral antidiabetic agent troglitazone improves beta cell responses to glucose in subjects with impaired glucose tolerance
    • Cavaghan MK, Ehrmann DA, Byrne MM, Polonsky KS. Treatment with the oral antidiabetic agent troglitazone improves beta cell responses to glucose in subjects with impaired glucose tolerance. J Clin Invest 100: 530-537, 1997.
    • (1997) J Clin Invest , vol.100 , pp. 530-537
    • Cavaghan, M.K.1    Ehrmann, D.A.2    Byrne, M.M.3    Polonsky, K.S.4
  • 13
    • 0035205594 scopus 로고    scopus 로고
    • A systematic review of the clinical effectiveness of pioglitazone in the treatment of type 2 diabetes mellitus
    • Discussion 1791
    • Chilcott J, Tappenden P, Jones ML, Wight JP. A systematic review of the clinical effectiveness of pioglitazone in the treatment of type 2 diabetes mellitus. Clin Ther 23: 1792-1823, Discussion 1791, 2001.
    • (2001) Clin Ther , vol.23 , pp. 1792-1823
    • Chilcott, J.1    Tappenden, P.2    Jones, M.L.3    Wight, J.P.4
  • 14
    • 0030724591 scopus 로고    scopus 로고
    • Pathogenesis of type 2 diabetes: Metabolic and molecular implications for identifying diabetes genes
    • DeFronzo R. Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying diabetes genes. Diabetes Rev 5: 177-269, 1997.
    • (1997) Diabetes Rev , vol.5 , pp. 177-269
    • DeFronzo, R.1
  • 15
    • 0024026298 scopus 로고
    • Lilly lecture 1987. The triumvirate: Beta-cell, muscle, liver. A collusion responsible for NIDDM
    • DeFronzo RA. Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 37: 667-687, 1988.
    • (1988) Diabetes , vol.37 , pp. 667-687
    • DeFronzo, R.A.1
  • 17
    • 0029126350 scopus 로고
    • Reciprocal variations in insulin-stimulated glucose uptake and pancreatic insulin secretion in women with normal glucose tolerance
    • Diamond MP, Thornton K, Connolly-Diamond M, Sherwin RS, De-Fronzo RA. Reciprocal variations in insulin-stimulated glucose uptake and pancreatic insulin secretion in women with normal glucose tolerance. J Soc Gynecol Investig 2: 708-715, 1995.
    • (1995) J Soc Gynecol Investig , vol.2 , pp. 708-715
    • Diamond, M.P.1    Thornton, K.2    Connolly-Diamond, M.3    Sherwin, R.S.4    De-Fronzo, R.A.5
  • 18
    • 0346157020 scopus 로고    scopus 로고
    • Pioglitazone preserves pancreatic islet structure and insulin secretory function in three murine models of type 2 diabetes
    • Diani AR, Sawada G, Wyse B, Murray FT, Khan M. Pioglitazone preserves pancreatic islet structure and insulin secretory function in three murine models of type 2 diabetes. Am J Physiol Endocrinol Metab 286: E116-E122, 2004.
    • (2004) Am J Physiol Endocrinol Metab , vol.286
    • Diani, A.R.1    Sawada, G.2    Wyse, B.3    Murray, F.T.4    Khan, M.5
  • 20
    • 12244299450 scopus 로고    scopus 로고
    • beta-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: A new analysis
    • Ferrannini E, Gastaldelli A, Miyazaki Y, Matsuda M, Mari A, De-Fronzo RA. beta-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis. J Clin Endocrinol Metab 90: 493-500, 2005.
    • (2005) J Clin Endocrinol Metab , vol.90 , pp. 493-500
    • Ferrannini, E.1    Gastaldelli, A.2    Miyazaki, Y.3    Matsuda, M.4    Mari, A.5    De-Fronzo, R.A.6
  • 22
    • 21244443895 scopus 로고    scopus 로고
    • Sulfonylurea agents exhibit peroxisome proliferator-activated receptor gamma agonistic activity
    • Fukuen S, Iwaki M, Yasui A, Makishima M, Matsuda M, Shimomura I. Sulfonylurea agents exhibit peroxisome proliferator-activated receptor gamma agonistic activity. J Biol Chem 280: 23653-23659, 2005.
    • (2005) J Biol Chem , vol.280 , pp. 23653-23659
    • Fukuen, S.1    Iwaki, M.2    Yasui, A.3    Makishima, M.4    Matsuda, M.5    Shimomura, I.6
  • 23
    • 0942279564 scopus 로고    scopus 로고
    • Beta-cell dysfunction and glucose intolerance: Results from the San Antonio metabolism (SAM) study
    • Gastaldelli A, Ferrannini E, Miyazaki Y, Matsuda M, DeFronzo RA. Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study. Diabetologia 47: 31-39, 2004.
    • (2004) Diabetologia , vol.47 , pp. 31-39
    • Gastaldelli, A.1    Ferrannini, E.2    Miyazaki, Y.3    Matsuda, M.4    DeFronzo, R.A.5
  • 26
    • 33845284881 scopus 로고    scopus 로고
    • Effect of pioglitazone on insulin secretion in patients with both impaired fasting glucose and impaired glucose tolerance
    • González-Ortiz M, Hernández-Salazar E, Kam-Ramos AM, Martínez-Abundis E. Effect of pioglitazone on insulin secretion in patients with both impaired fasting glucose and impaired glucose tolerance. Diabetes Res Clin Pract 75: 115-118, 2007.
    • (2007) Diabetes Res Clin Pract , vol.75 , pp. 115-118
    • González-Ortiz, M.1    Hernández-Salazar, E.2    Kam-Ramos, A.M.3    Martínez-Abundis, E.4
  • 27
    • 0024392514 scopus 로고
    • Glucose and free fatty acid metabolism in non-insulin- dependent diabetes mellitus. Evidence for multiple sites of insulin resistance
    • Groop LC, Bonadonna RC, DelPrato S, Ratheiser K, Zyck K, Ferrannini E, DeFronzo RA. Glucose and free fatty acid metabolism in non-insulin- dependent diabetes mellitus. Evidence for multiple sites of insulin resistance. J Clin Invest 84: 205-213, 1989.
    • (1989) J Clin Invest , vol.84 , pp. 205-213
    • Groop, L.C.1    Bonadonna, R.C.2    DelPrato, S.3    Ratheiser, K.4    Zyck, K.5    Ferrannini, E.6    DeFronzo, R.A.7
  • 29
    • 0033613181 scopus 로고    scopus 로고
    • Troglitazone prevents mitochondrial alterations, beta cell destruction, and diabetes in obese prediabetic rats
    • Higa M, Zhou YT, Ravazzola M, Baetens D, Orci L, Unger RH. Troglitazone prevents mitochondrial alterations, beta cell destruction, and diabetes in obese prediabetic rats. Proc Natl Acad Sci USA 96: 11513-11518, 1999.
    • (1999) Proc Natl Acad Sci USA , vol.96 , pp. 11513-11518
    • Higa, M.1    Zhou, Y.T.2    Ravazzola, M.3    Baetens, D.4    Orci, L.5    Unger, R.H.6
  • 32
    • 0041883085 scopus 로고    scopus 로고
    • Influence of rosiglitazone treatment on beta-cell function in type 2 diabetes: Evidence of an increased ability of glucose to entrain high-frequency insulin pulsatility
    • Juhl CB, Hollingdal M, Porksen N, Prange A, Lonnqvist F, Schmitz O. Influence of rosiglitazone treatment on beta-cell function in type 2 diabetes: evidence of an increased ability of glucose to entrain high-frequency insulin pulsatility. J Clin Endocrinol Metab 88: 3794-3800, 2003.
    • (2003) J Clin Endocrinol Metab , vol.88 , pp. 3794-3800
    • Juhl, C.B.1    Hollingdal, M.2    Porksen, N.3    Prange, A.4    Lonnqvist, F.5    Schmitz, O.6
  • 33
    • 0034853485 scopus 로고    scopus 로고
    • Clinical review 135: The importance of beta-cell failure in the development and progression of type 2 diabetes
    • Kahn SE. Clinical review 135: The importance of beta-cell failure in the development and progression of type 2 diabetes. J Clin Endocrinol Metab 86: 4047-4058, 2001.
    • (2001) J Clin Endocrinol Metab , vol.86 , pp. 4047-4058
    • Kahn, S.E.1
  • 35
    • 1442272497 scopus 로고    scopus 로고
    • Effects of sustained reduction in plasma FFA concentration on insulin secretion in non-diabetic subjects with a strong family history of T2DM (Abstract)
    • Kashyap SR, Suraamornkul S, Bajaj M, Belfort R, Berria R, Mandarino L, DeFronzo R, Cusi K. Effects of sustained reduction in plasma FFA concentration on insulin secretion in non-diabetic subjects with a strong family history of T2DM (Abstract). Diabetes 52: A336, 2003.
    • (2003) Diabetes , vol.52
    • Kashyap, S.R.1    Suraamornkul, S.2    Bajaj, M.3    Belfort, R.4    Berria, R.5    Mandarino, L.6    DeFronzo, R.7    Cusi, K.8
  • 36
    • 13844262626 scopus 로고    scopus 로고
    • Structural and functional analysis of pancreatic islets preserved by pioglitazone in db/db mice
    • Kawasaki F, Matsuda M, Kanda Y, Inoue H, Kaku K. Structural and functional analysis of pancreatic islets preserved by pioglitazone in db/db mice. Am J Physiol Endocrinol Metab 288: E510-E518, 2005.
    • (2005) Am J Physiol Endocrinol Metab , vol.288
    • Kawasaki, F.1    Matsuda, M.2    Kanda, Y.3    Inoue, H.4    Kaku, K.5
  • 38
    • 0033864402 scopus 로고    scopus 로고
    • Identification and functional characterization of the peroxisomal proliferator response element in rat GLUT2 promoter
    • Kim HI, Kim JW, Kim SH, Cha JY, Kim KS, Ahn YH. Identification and functional characterization of the peroxisomal proliferator response element in rat GLUT2 promoter. Diabetes 49: 1517-1524, 2000.
    • (2000) Diabetes , vol.49 , pp. 1517-1524
    • Kim, H.I.1    Kim, J.W.2    Kim, S.H.3    Cha, J.Y.4    Kim, K.S.5    Ahn, Y.H.6
  • 39
    • 23644434430 scopus 로고    scopus 로고
    • Rosiglitazone reduces glucose-stimulated insulin secretion rate and increases insulin clearance in nondiabetic, insulin-resistant individuals
    • Kim SH, Abbasi F, Chu JW, McLaughlin TL, Lamendola C, Polonsky KS, Reaven GM. Rosiglitazone reduces glucose-stimulated insulin secretion rate and increases insulin clearance in nondiabetic, insulin-resistant individuals. Diabetes 54: 2447-2452, 2005.
    • (2005) Diabetes , vol.54 , pp. 2447-2452
    • Kim, S.H.1    Abbasi, F.2    Chu, J.W.3    McLaughlin, T.L.4    Lamendola, C.5    Polonsky, K.S.6    Reaven, G.M.7
  • 40
    • 0036068327 scopus 로고    scopus 로고
    • Troglitazone but not metformin restores insulin-stimulated phosphoinositide 3-kinase activity and increases p110beta protein levels in skeletal muscle of type 2 diabetic subjects
    • Kim YB, Ciaraldi TP, Kong A, Kim D, Chu N, Mohideen P, Mudaliar S, Henry RR, Kahn BB. Troglitazone but not metformin restores insulin-stimulated phosphoinositide 3-kinase activity and increases p110beta protein levels in skeletal muscle of type 2 diabetic subjects. Diabetes 51: 443-448, 2002.
    • (2002) Diabetes , vol.51 , pp. 443-448
    • Kim, Y.B.1    Ciaraldi, T.P.2    Kong, A.3    Kim, D.4    Chu, N.5    Mohideen, P.6    Mudaliar, S.7    Henry, R.R.8    Kahn, B.B.9
  • 42
    • 1642414416 scopus 로고    scopus 로고
    • Rosiglitazone prevents the impairment of human islet function induced by fatty acids: Evidence for a role of PPARγ2 in the modulation of insulin secretion
    • Lupi R, Del Guerra S, Marselli L, Bugliani M, Boggi U, Mosca F, Marchetti P, Del Prato S. Rosiglitazone prevents the impairment of human islet function induced by fatty acids: evidence for a role of PPARγ2 in the modulation of insulin secretion. Am J Physiol Endocrinol Metab 286: E560-E567, 2004.
    • (2004) Am J Physiol Endocrinol Metab , vol.286
    • Lupi, R.1    Del Guerra, S.2    Marselli, L.3    Bugliani, M.4    Boggi, U.5    Mosca, F.6    Marchetti, P.7    Del Prato, S.8
  • 46
    • 0036311151 scopus 로고    scopus 로고
    • Assessing insulin secretion by modeling in multiple-meal tests: Role of potentiation
    • Mari A, Tura A, Gastaldelli A, Ferrannini E. Assessing insulin secretion by modeling in multiple-meal tests: role of potentiation. Diabetes 51, Suppl 1: S221-S226, 2002.
    • (2002) Diabetes , vol.51 , Issue.SUPPL. 1
    • Mari, A.1    Tura, A.2    Gastaldelli, A.3    Ferrannini, E.4
  • 47
    • 7044260753 scopus 로고    scopus 로고
    • Pioglitazone reduces islet triglyceride content and restores impaired glucose-stimulated insulin secretion in heterozygous peroxisome proliferator-activated receptor-gamma- deficient mice on a high-fat diet
    • Matsui J, Terauchi Y, Kubota N, Takamoto I, Eto K, Yamashita T, Komeda K, Yamauchi T, Kamon J, Kita S, Noda M, Kadowaki T. Pioglitazone reduces islet triglyceride content and restores impaired glucose-stimulated insulin secretion in heterozygous peroxisome proliferator-activated receptor-gamma- deficient mice on a high-fat diet. Diabetes 53: 2844-2854, 2004.
    • (2004) Diabetes , vol.53 , pp. 2844-2854
    • Matsui, J.1    Terauchi, Y.2    Kubota, N.3    Takamoto, I.4    Eto, K.5    Yamashita, T.6    Komeda, K.7    Yamauchi, T.8    Kamon, J.9    Kita, S.10    Noda, M.11    Kadowaki, T.12
  • 51
  • 52
    • 0036517099 scopus 로고    scopus 로고
    • Dose-response effect of pioglitazone on insulin sensitivity and insulin secretion in type 2 diabetes
    • Miyazaki Y, Matsuda M, DeFronzo RA. Dose-response effect of pioglitazone on insulin sensitivity and insulin secretion in type 2 diabetes. Diabetes Care 25: 517-523, 2002.
    • (2002) Diabetes Care , vol.25 , pp. 517-523
    • Miyazaki, Y.1    Matsuda, M.2    DeFronzo, R.A.3
  • 53
    • 0035124186 scopus 로고    scopus 로고
    • New oral therapies for type 2 diabetes mellitus: The glitazones or insulin sensitizers
    • Mudaliar S, Henry RR. New oral therapies for type 2 diabetes mellitus: the glitazones or insulin sensitizers. Annu Rev Med 52: 239-257, 2001.
    • (2001) Annu Rev Med , vol.52 , pp. 239-257
    • Mudaliar, S.1    Henry, R.R.2
  • 56
    • 0024590095 scopus 로고
    • Relationship between glucose tolerance, insulin secretion, and insulin action in non-obese individuals with varying degrees of glucose tolerance
    • Reaven GM, Hollenbeck CB, Chen YD. Relationship between glucose tolerance, insulin secretion, and insulin action in non-obese individuals with varying degrees of glucose tolerance. Diabetologia 32: 52-55, 1989.
    • (1989) Diabetologia , vol.32 , pp. 52-55
    • Reaven, G.M.1    Hollenbeck, C.B.2    Chen, Y.D.3
  • 59
    • 0032488968 scopus 로고    scopus 로고
    • Troglitazone lowers islet fat and restores beta cell function of Zucker diabetic fatty rats
    • Shimabukuro M, Zhou YT, Lee Y, Unger RH. Troglitazone lowers islet fat and restores beta cell function of Zucker diabetic fatty rats. J Biol Chem 273: 3547-3550, 1998.
    • (1998) J Biol Chem , vol.273 , pp. 3547-3550
    • Shimabukuro, M.1    Zhou, Y.T.2    Lee, Y.3    Unger, R.H.4
  • 60
    • 0026504160 scopus 로고
    • Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance
    • Van Cauter E, Mestrez F, Sturis J, Polonsky KS. Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes 41: 368-377, 1992.
    • (1992) Diabetes , vol.41 , pp. 368-377
    • Van Cauter, E.1    Mestrez, F.2    Sturis, J.3    Polonsky, K.S.4
  • 61
    • 0030977450 scopus 로고    scopus 로고
    • Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids
    • Vidal-Puig AJ, Considine RV, Jimenez-Linan M, Werman A, Pories WJ, Caro JF, Flier JS. Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids. J Clin Invest 99: 2416-2422, 1997.
    • (1997) J Clin Invest , vol.99 , pp. 2416-2422
    • Vidal-Puig, A.J.1    Considine, R.V.2    Jimenez-Linan, M.3    Werman, A.4    Pories, W.J.5    Caro, J.F.6    Flier, J.S.7
  • 63
    • 2942640242 scopus 로고    scopus 로고
    • Pharmacological treatment of insulin resistance at two different stages in the evolution of type 2 diabetes: Impact on glucose tolerance and beta-cell function
    • Xiang AH, Peters RK, Kjos SL, Goico J, Ochoa C, Marroquin A, Tan S, Hodis HN, Azen SP, Buchanan TA. Pharmacological treatment of insulin resistance at two different stages in the evolution of type 2 diabetes: impact on glucose tolerance and beta-cell function. J Clin Endocrinol Metab 89: 2846-2851, 2004.
    • (2004) J Clin Endocrinol Metab , vol.89 , pp. 2846-2851
    • Xiang, A.H.1    Peters, R.K.2    Kjos, S.L.3    Goico, J.4    Ochoa, C.5    Marroquin, A.6    Tan, S.7    Hodis, H.N.8    Azen, S.P.9    Buchanan, T.A.10
  • 64
    • 33644762010 scopus 로고    scopus 로고
    • Effect of pioglitazone on pancreatic beta-cell function and diabetes risk in Hispanic women with prior gestational diabetes
    • Xiang AH, Peters RK, Kjos SL, Marroquin A, Goico J, Ochoa C, Kawakubo M, Buchanan TA. Effect of pioglitazone on pancreatic beta-cell function and diabetes risk in Hispanic women with prior gestational diabetes. Diabetes 55: 517-522, 2006.
    • (2006) Diabetes , vol.55 , pp. 517-522
    • Xiang, A.H.1    Peters, R.K.2    Kjos, S.L.3    Marroquin, A.4    Goico, J.5    Ochoa, C.6    Kawakubo, M.7    Buchanan, T.A.8
  • 65
    • 19244365650 scopus 로고    scopus 로고
    • Thiazolidinediones
    • Yki-Jarvinen H. Thiazolidinediones. N Engl J Med 351: 1106-1118, 2004.
    • (2004) N Engl J Med , vol.351 , pp. 1106-1118
    • Yki-Jarvinen, H.1
  • 66
    • 0036789137 scopus 로고    scopus 로고
    • The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects
    • Yu JG, Javorschi S, Hevener AL, Kruszynska YT, Norman RA, Sinha M, Olefsky JM. The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects. Diabetes 51: 2968-2974, 2002.
    • (2002) Diabetes , vol.51 , pp. 2968-2974
    • Yu, J.G.1    Javorschi, S.2    Hevener, A.L.3    Kruszynska, Y.T.4    Norman, R.A.5    Sinha, M.6    Olefsky, J.M.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.